Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 18 Nov 2024

In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis

in Vaccines and Molecular Therapeutics

Jin-Seung Yun
A Reum Kim
Soo Min Kim
Eunkyung Shin
Sang-Jun Ha
Dokeun Kim
Hye-Sook Jeong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474346

1,981 views

Original Research

Published on 13 Nov 2024

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study

in Vaccines and Molecular Therapeutics

Nayab Batool Rizvi
Maryam Bibi
Muhmmad Zeeshan Rana
Sehrish Zaffar
Hassam Farooq

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448408

3,526 views

Original Research

Published on 11 Nov 2024

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

in Vaccines and Molecular Therapeutics

Mohamed A. Kamal
Matthew P. Kosloski
Ching-Ha Lai
Michael A. Partridge
Manoj Rajadhyaksha
Vanaja Kanamaluru
Ashish Bansal
Arsalan Shabbir
Brad Shumel
Marius Ardeleanu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466372

2,827 views

Review

Published on 08 Nov 2024

Personalized cancer vaccine design using AI-powered technologies

in Vaccines and Molecular Therapeutics

Anant Kumar
Shriniket Dixit
Kathiravan Srinivasan
Dinakaran M
P. M. Durai Raj Vincent

Frontiers in Immunology

doi 10.3389/fimmu.2024.1357217

6,778 views
3 citations

Clinical Trial

Published on 07 Nov 2024

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

in Vaccines and Molecular Therapeutics

Zhenzhen Liang
Xu Chen
Bo Xing
Xiaosong Hu
Miaomiao Liu
Xinpei Zhang
Yugang Shen
Yan Wang
Yingping Chen
Huakun Lv

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444686

1,206 views

Review

Published on 07 Nov 2024

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

in Vaccines and Molecular Therapeutics

Carla Nel
John Frater

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478703

1,801 views

Original Research

Published on 06 Nov 2024

Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII.2) local isolates of Bangladesh

in Vaccines and Molecular Therapeutics

Mohammad Aynul Haque
Md. Enamul Haque
Mst. Kohinoor Parvin
Md. Mostofa Kamal
Tanbin Rubaiya Islam
Mohammad Sadekuzzaman
Md. Ariful Islam
Mst. Minara Khatun
Muhammad Tofazzal Hossain
Mohammad Asir Uddin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482314

1,017 views
1 citation

Original Research

Published on 06 Nov 2024

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic

in Vaccines and Molecular Therapeutics

Rongrong Dai
Weiyu Peng
Nani Xu
Pan Qin
Linling Ding
Qianhui Hua
Jianmin Jiang
Fang He
Hangjie Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476186

1,196 views

Original Research

Published on 05 Nov 2024

Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling

in Vaccines and Molecular Therapeutics

Zhuwei Liang
Chao Zhang
Xiaoyu Liu
Kaiyue Yang
Zhile Xiong
Bingshao Liang
Jialiang Mai
Xiaojun Xiao
Jie Liu
Pingchang Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428079

1,384 views

Original Research

Published on 04 Nov 2024

A dual-purpose humanized mouse model for testing antiviral strategies against both SIV and HIV

in Vaccines and Molecular Therapeutics

Ella Barnett
Snehal Kaginkar
Kimberly Schmitt
Leila Remling-Mulder
Ramesh Akkina

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491481

1,277 views

Systematic Review

Published on 01 Nov 2024

COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis

in Vaccines and Molecular Therapeutics

Ariela Hoxha
Giovanni Striani
Marco Lovisotto
Paolo Simioni
Andrea Doria
Roberta Ramonda

Frontiers in Immunology

doi 10.3389/fimmu.2024.1503895

1,842 views

Original Research

Published on 30 Oct 2024

Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against S. Paratyphi A in human samples

in Vaccines and Molecular Therapeutics

Martina Carducci
Luisa Massai
Elisa Lari
Bianca Semplici
Silvia Grappi
Noshi Maria
Elizabeth Jones
Valentino Conti
Pietro Piu
Francesco Berlanda Scorza

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443137

940 views

Review

Published on 29 Oct 2024

Mycobacterium w - a promising immunotherapeutic intervention for diseases

in Vaccines and Molecular Therapeutics

Kirsten Stefan
Ryan Gordon
Annah Rolig
Alexander Honkala
Dhanir Tailor
Lara E. Davis
Rajiv I. Modi
Manjul Joshipura
Bakulesh Khamar
Sanjay V. Malhotra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450118

1,569 views

Original Research

Published on 16 Oct 2024

Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human sera

in Vaccines and Molecular Therapeutics

Martina Carducci
Luisa Massai
Elisa Lari
Bianca Semplici
Maria Grazia Aruta
Daniele De Simone
Pietro Piu
Emanuele Montomoli
Francesco Berlanda Scorza
Silvia Grappi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466869

982 views

Original Research

Published on 14 Oct 2024

Coxiella burnetii Nine Mile phase I primary infection derived protective immunity against C. burnetii reinfection in mice depends on both B and T cells, but T cells play a critical role

in Vaccines and Molecular Therapeutics

Shawkat Alam
Venkatesh Kumaresan
Rajesh Palanisamy
Yan Zhang
Janakiram Seshu
Na Xiong
Guoquan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427822

978 views

Original Research

Published on 14 Oct 2024

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice

in Vaccines and Molecular Therapeutics

Gangyuan Ma
Zeping Xu
Chinyu Li
Feng Zhou
Bobo Hu
Junwei Guo
Changwen Ke
Liqing Chen
Guilin Zhang
Hungyan Lau

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451433

1,342 views

Navigation group

Articles

In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

Personalized cancer vaccine design using AI-powered technologies

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII.2) local isolates of Bangladesh

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic

Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling

A dual-purpose humanized mouse model for testing antiviral strategies against both SIV and HIV

COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis

Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against S. Paratyphi A in human samples

Mycobacterium w - a promising immunotherapeutic intervention for diseases

Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human sera

Coxiella burnetii Nine Mile phase I primary infection derived protective immunity against C. burnetii reinfection in mice depends on both B and T cells, but T cells play a critical role

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice